Athira Pharma Inc (NAS:ATHA)
$ 0.5102 0.0198 (4.04%) Market Cap: 19.60 Mil Enterprise Value: -71.51 Mil PE Ratio: 0 PB Ratio: 0.23 GF Score: 42/100

Athira Pharma Inc at Needham Neuroscience Forum (Virtual) Transcript

Mar 15, 2023 / 02:50PM GMT
Release Date Price: $2.69 (-3.58%)
Ami Fadia
Needham & Company - Analyst

Good morning, everyone, again. This is Ami Fadia, very happy to host our next company, Athira Pharma. Thank you so much, Mark, Hans, Rachel for joining us today for the session. Just by way of a reminder to our listeners, if you have any questions that you'd like me to ask the team, feel free to send it over to me through the chat.

And with that, Mark, very glad to have you and the team here today. Thank you so much.

Mark Litton
Athira Pharma, Inc. - President & CEO

Thank you for having us.

Questions & Answers

Ami Fadia
Needham & Company - Analyst

Great. Perhaps we can start with a broader question around the CNS space. Neuroscience has been undergoing a renaissance period over the last couple of years. I wanted to know in your view, where has the most amount of progress been made, and where do you see and a need for more progress to be made from here?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot